MIT Jameel Clinic and Sanofi join forces to advance research in artificial intelligence and health

Within the collaboration, we will work together to progress the development of AI and ML capabilities to revolutionize healthcare and advance impactful, effective drug discovery.

Jameel Clinic Sanofi Partnership.jpg

Photo: Sanofi trispecific monoclonal antibody (Tri-mAb). Courtesy of Yu Qiu, Principal Scientist, Biologics Research, Sanofi R&D.

The Abdul Latif Jameel Clinic for Machine Learning in Health at MIT has reached a historic milestone that marks the first step in a long-term strategic collaboration with Sanofi, a multinational diversified healthcare company. The Jameel Clinic and Sanofi pharmaceutical research teams will collaborate on the development and application of artificial intelligence (AI) and machine learning capabilities to revolutionize healthcare and advance impactful and effective drug discovery and development.

An initiative of:

CJ-Logo.png
MIT-logo-footer.png
  • Twitter - White Circle
  • LinkedIn - White Circle

Jameel Clinic

77 Massachusetts Ave.
Cambridge, MA 02139-4307

jclinic-info@mit.edu

Media inquires: 

jclinic-media@mit.edu

Accessibility